Exact Mass: 312.189665
Exact Mass Matches: 312.189665
Found 195 metabolites which its exact mass value is equals to given mass value 312.189665,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Granisetron
C18H24N4O (312.19500139999997)
Granisetron is only found in individuals that have used or taken this drug. It is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]Granisetron is a potent, selective antagonist of 5-HT3 receptors. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.
Praziquantel
C19H24N2O2 (312.18376839999996)
Praziquantel is only found in individuals that have used or taken this drug. It is an anthelmintic used in most schistosome and many cestode infestations. [PubChem]Praziquantel works by causing severe spasms and paralysis of the worms muscles. This paralysis is accompanied - and probably caused - by a rapid Ca 2+ influx inside the schistosome. Morphological alterations are another early effect of praziquantel. These morphological alterations are accompanied by an increased exposure of schistosome antigens at the parasite surface. The worms are then either completely destroyed in the intestine or passed in the stool. An interesting quirk of praziquantel is that it is relatively ineffective against juvenile schistosomes. While initially effective, effectiveness against schistosomes decreases until it reaches a minimum at 3-4 weeks. Effectiveness then increases again until it is once again fully effective at 6-7 weeks. Glutathione S-transferase (GST), an essential detoxification enzyme in parasitic helminths, is a major vaccine target and a drug target against schistosomiasis. Schistosome calcium ion channels are currently the only known target of praziquantel. P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
norajmaline
C19H24N2O2 (312.18376839999996)
An organonitrogen heterocyclic compound that is ajmaline which is lacking the methyl substituent attached to the nitrogen of the dihydroindole moiety.
(±)-2,4,6-Triphenyl-1-hexene
Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating. Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating
1,3,5-Triphenylcyclohexane
1,3,5-Triphenylcyclohexane is a packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating. Packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating
1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene
1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue
1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene
1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue
1-Isopropyl-6-methylergoline-8-carboxylic acid
C19H24N2O2 (312.18376839999996)
Xylamidine
C19H24N2O2 (312.18376839999996)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
Norajmaline
Norajmaline is a member of the class of compounds known as ajmaline-sarpagine alkaloids. Ajmaline-sarpagine alkaloids are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. Norajmaline is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Norajmaline can be found in a number of food items such as roselle, chayote, savoy cabbage, and onion-family vegetables, which makes norajmaline a potential biomarker for the consumption of these food products.
9E-Isomer-Neolaugerine|neolaugerine
C19H24N2O2 (312.18376839999996)
N(1)-desacetyl 18-hydroxyisoretuline|N-desacetyl-18-hydroxyisoretuline|Na-Desacetyl-18-hydroxyisoretuline
C19H24N2O2 (312.18376839999996)
4beta-acetoxy-9beta,10beta,15alpha-trihydroxyprobotrydial
(1S*,6R*,7S*,8S*,11R*)-6,11-diphenyltricyclo[6.2.2.02,7]dodeca-2,9-diene
(3S,6S)-3-acetoxy-2,2,6-trimethyl-6-([1S,4R]-4-hydroperoxy-4-methylcyclohex-2-en-1-yl)tetrahydropyran
17-Hydroxy-16-decarbomethoxydihydroepiajmalicine
C19H24N2O2 (312.18376839999996)
3-Ethyl-3-hydroxy-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9-one
C19H24N2O2 (312.18376839999996)
(2S,3R,4S,4aR,7S,7aS,3R,5R,Z)-2-(3,5-dimethylhept-1-enyl)-3,4-dihydroxy-7-methyl-4,4a,7,7a-tetrahydro-2H-furo[3,4-b]pyran-5(3H)-one|fusidilactone E
Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannonanoic acid
Artemotil
Artemotil is an artemisinin derivative. Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2]. Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2].
praziquantel
C19H24N2O2 (312.18376839999996)
P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8927; ORIGINAL_PRECURSOR_SCAN_NO 8925 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8934; ORIGINAL_PRECURSOR_SCAN_NO 8932 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8954; ORIGINAL_PRECURSOR_SCAN_NO 8953 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8977; ORIGINAL_PRECURSOR_SCAN_NO 8976 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8993; ORIGINAL_PRECURSOR_SCAN_NO 8991 CONFIDENCE standard compound; INTERNAL_ID 2202 [Raw Data] CB144_Praziquantel_pos_50eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_40eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_30eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_20eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_10eV_CB000054.txt CONFIDENCE standard compound; EAWAG_UCHEM_ID 3272
granisetron
C18H24N4O (312.19500139999997)
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.
FA 17:3;O3
4-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid
2-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid
2-((4-Ethoxyphenyl)amino)-2-phenyl-N-propylacetamide
C19H24N2O2 (312.18376839999996)
5,6,14,15-DIBENZO-1,4-DIOXA-8,12-DIAZACYCLOPENTADECA-5,14-DIENE
C19H24N2O2 (312.18376839999996)
(2-n-benzylaminoethyl)-3-aminopropyl-trimethoxysilane,tech-90
4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE
C19H24N2O2 (312.18376839999996)
buta-1,3-diene,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,styrene
C19H24N2O2 (312.18376839999996)
N,N,N,N-TETRAMETHYL-N-[TRIS(DIMETHYLAMINO)PHOSPHORANYLIDENE]PHOSPHORIC TRIAMIDE
C10H30N6OP2 (312.19562299999996)
Granisetronum
C18H24N4O (312.19500139999997)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
(R)-Praziquantel
C19H24N2O2 (312.18376839999996)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Etidocaine hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
C19H24N2O2 (312.18376839999996)
1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide
C18H24N4O (312.19500139999997)
(3,5-dimethylphenyl)[4-(3-ethyl-4H-1,2,4-triazol-4-yl)piperidino]methanone
C18H24N4O (312.19500139999997)
2,3-dimethoxy-N-[4-(1-piperidinyl)phenyl]aniline
C19H24N2O2 (312.18376839999996)
(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(6R,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(6S,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C19H24N2O2 (312.18376839999996)
(1R,9R,10S,12R,13S,14R,17S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
C19H24N2O2 (312.18376839999996)
5-Methyl-4,4-pentamethylene-2-para-tolylpephydropyrrolo(3,4-C)pyrrole-1,3-dione
C19H24N2O2 (312.18376839999996)
(3S,4S)-5-Benzyloxy-3-(2-methoxyethoxymethoxy)-4-methylpentan-2-ol
1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene
1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene
(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid
A monounsaturated fatty acid that is (7Z)-heptadec-7-enoic acid which is substituted by a hydroxy group at position 14 and by oxo groups at positions 10 and 13.
(2r)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate
2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate
(3s)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
(3s,6s)-6-[(1s,4r)-4-hydroperoxy-4-methylcyclohex-2-en-1-yl]-2,2,6-trimethyloxan-3-yl acetate
2-(3-ethenylpiperidin-4-yl)-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone
C19H24N2O2 (312.18376839999996)
3-[2-(3-ethyl-1-methylpiperidin-4-ylidene)ethylidene]-7-methoxy-1h-indol-2-one
C19H24N2O2 (312.18376839999996)
(3z)-3-{2-[(3s,4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol
C19H24N2O2 (312.18376839999996)
12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
(3s)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
6-(4-hydroperoxy-4-methylcyclohex-2-en-1-yl)-2,2,6-trimethyloxan-3-yl acetate
15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
(9e)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
2-(3,5-dimethylhept-1-en-1-yl)-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one
2-(3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl)prop-2-en-1-yl acetate
(2r,15r,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol
C19H24N2O2 (312.18376839999996)
4-[(r)-[(2s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol
C19H24N2O2 (312.18376839999996)
15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol
C19H24N2O2 (312.18376839999996)
4β- Acetoxy- 9β,10β,15α-trihydroxyp robotrydial
{"Ingredient_id": "HBIN010263","Ingredient_name": "4\u03b2- Acetoxy- 9\u03b2,10\u03b2,15\u03b1-trihydroxyp robotrydial","Alias": "NA","Ingredient_formula": "C17H28O5","Ingredient_Smile": "CC1CC(C2C(CC3(C2(C1C(C3O)O)O)C)(C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42940","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s)-3-{5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
8-hydroxy-2-(1-hydroxyheptyl)-4-methoxy-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one
4-hydroxy-12-(1-hydroxyethyl)-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
2,3-dihydroxypropyl 13-hydroxytetradeca-2,4,8-trienoate
(4s,15r,16r,18s)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-5,7,9,11-tetraen-4-ol
C19H24N2O2 (312.18376839999996)
(3s)-1,1-dimethyl-8-(3-methylbut-2-en-1-yl)-2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid
C19H24N2O2 (312.18376839999996)
(12r,15r,17r,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-12,17-diol
C19H24N2O2 (312.18376839999996)
(1s,15s,16s,18r,20r)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraen-18-ol
C19H24N2O2 (312.18376839999996)
8-hydroxy-9-methyl-10-oxo-2-pentyl-2,3,4,5,8,9-hexahydrooxecin-3-yl acetate
(3as,8ar)-8a-[(2r,4r,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-2h,3h,8h-furo[2,3-b]indol-3a-ol
C19H24N2O2 (312.18376839999996)
(9e)-4-hydroxy-12-(1-hydroxyethyl)-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
(2s)-1,2,3,6-tetrahydroxyheptadeca-5,7,9-trien-4-one
(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-4-methoxy-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one
(1r,4r,7s,8s,9r,11s,12r)-7,12-dihydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(3z)-3-{2-[(4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol
C19H24N2O2 (312.18376839999996)
2-[(1s,9s,10r,11r,12e,17s)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-12-ylidene]ethanol
C19H24N2O2 (312.18376839999996)
3-{5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-13-ol
C19H24N2O2 (312.18376839999996)
(1s,2s,3r,4r,6e,10r)-2-hydroxy-6-(hydroxymethyl)-3-isopropyl-10-methyl-11-oxabicyclo[8.1.0]undec-6-en-4-yl acetate
4-[(r)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol
C19H24N2O2 (312.18376839999996)
(5s,6e,8s,9e,13r,14r)-5,8,13-trihydroxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-6,9-dien-2-one
9-hydroxy-3-methyl-2-oxo-10-pentyl-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate
15-ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-19-one
C19H24N2O2 (312.18376839999996)
15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-12,17-diol
C19H24N2O2 (312.18376839999996)
1,8-dihydroxy-5-isopropyl-2,8-dimethyl-11-oxatricyclo[5.3.1.0²,⁶]undecan-9-yl acetate
(15s,17r,19r)-15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
(3r)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
(2s,3r,4s,4ar,7s,7as)-2-[(1z)-3,5-dimethylhept-1-en-1-yl]-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one
{16-methyl-17-oxa-1,11-diazapentacyclo[10.7.1.0²,⁷.0⁸,²⁰.0¹⁴,¹⁹]icosa-2,4,6,8(20)-tetraen-15-yl}methanol
C19H24N2O2 (312.18376839999996)
15-(1-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
(9r,12r,13s,14r,16s,17s,18r)-13-ethyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-14,18-diol
C19H24N2O2 (312.18376839999996)
(3r,4s,5s,7r,9e,11s,12r)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
5-(8-hydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl)pentan-2-yl acetate
(13s,15r)-15-ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-19-one
C19H24N2O2 (312.18376839999996)
4-({5-ethyl-1-azabicyclo[2.2.2]octan-2-yl}(hydroxy)methyl)quinolin-6-ol
C19H24N2O2 (312.18376839999996)
(8r,15r)-15-ethyl-8-hydroxy-1,11-diazapentacyclo[9.7.1.0²,⁷.0⁸,¹⁹.0¹⁵,¹⁹]nonadeca-2,4,6-trien-18-one
C19H24N2O2 (312.18376839999996)
(3z)-3-{2-[(4e)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol
C19H24N2O2 (312.18376839999996)
(s)-[(2-amino-1-hydroxy-3-methylbutylidene)amino][(2s,4s,5r)-4-carbamimidamido-1-azabicyclo[3.1.0]hexan-2-yl]acetic acid
C13H24N6O3 (312.19097939999995)
1,1-dimethyl-8-(3-methylbut-2-en-1-yl)-2h,3h,4h,9h-pyrido[3,4-b]indole-3-carboxylic acid
C19H24N2O2 (312.18376839999996)
[(1s,12r)-13-(hydroxymethyl)-16-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-15-yl]methanol
C19H24N2O2 (312.18376839999996)
(2s)-5-[(2s,6e,8r,9r)-8-hydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl]pentan-2-yl acetate
2-[(3r,4s)-3-ethenylpiperidin-4-yl]-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone
C19H24N2O2 (312.18376839999996)
6-(2,4-dihydroxyundecyl)-4-hydroxy-3-methylpyran-2-one
(1s,15r,16s,18r,20r)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraen-18-ol
C19H24N2O2 (312.18376839999996)
6-[(2s,4r)-2,4-dihydroxyundecyl]-4-hydroxy-3-methylpyran-2-one
[(12s,14s,15s,16r,19s)-16-methyl-17-oxa-1,11-diazapentacyclo[10.7.1.0²,⁷.0⁸,²⁰.0¹⁴,¹⁹]icosa-2,4,6,8(20)-tetraen-15-yl]methanol
C19H24N2O2 (312.18376839999996)
(3r)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
(1r,2r,3r,4r,7r,8s,10r,11r)-2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate
(15s,17r,19r)-15-[(1r)-1-hydroxyethyl]-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
4-[(r)-[(2r,4r,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol
C19H24N2O2 (312.18376839999996)
7,12-dihydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
[(2-amino-1-hydroxy-3-methylbutylidene)amino]({4-carbamimidamido-1-azabicyclo[3.1.0]hexan-2-yl})acetic acid
C13H24N6O3 (312.19097939999995)
2-[(1s,9s,10s,11r,12z,17s)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-12-ylidene]ethanol
C19H24N2O2 (312.18376839999996)
2-[(1s,9s,10s,11r,17s)-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-12-ylidene]ethanol
C19H24N2O2 (312.18376839999996)
(3ar,8as)-8a-[(4r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-2h,3h,8h-furo[2,3-b]indol-3a-ol
C19H24N2O2 (312.18376839999996)
(3z)-3-{2-[(3r,4e)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol
C19H24N2O2 (312.18376839999996)
(15s,17s,19r)-15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraen-18-ol
C19H24N2O2 (312.18376839999996)
(5r,6e,8s,9e,13s,14r)-4,5,8-trihydroxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-6,9-dien-2-one
5,8-dihydroxy-9-(hydroxymethyl)-5,13,14-trimethyl-1-oxacyclotetradeca-6,9-dien-2-one
(13r,15s,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-13-ol
C19H24N2O2 (312.18376839999996)
2-[(3r,3as,4s,5s,8r,8as)-3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl]prop-2-en-1-yl acetate
(3r,4r,5z,9s,10r)-9-hydroxy-3-methyl-2-oxo-10-pentyl-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate
(1r,4r,7r,8s,9r,11s,12s)-7,12-dihydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(15s,17s,19r)-15-[(1r)-1-hydroxyethyl]-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol
C19H24N2O2 (312.18376839999996)
{6-methoxy-4-methyl-6-[(4e,6e)-6-methylocta-4,6-dien-1-yl]-1,2-dioxan-3-yl}acetic acid
2-[10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-12-ylidene]ethanol
C19H24N2O2 (312.18376839999996)
(1r,4r,7s,8s,9r,11s,12s)-7,12-dihydroxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate
(3s,4r,5s,7r,9e,11s,12s)-4-hydroxy-12-[(1s)-1-hydroxyethyl]-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
(3r)-3-{5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}-3-(2-hydroxyethyl)indol-2-ol
C19H24N2O2 (312.18376839999996)
15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-16,17-diol
C19H24N2O2 (312.18376839999996)
(2s)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate
(1s,2r,5s,6s,7s,8s,9s)-1,8-dihydroxy-5-isopropyl-2,8-dimethyl-11-oxatricyclo[5.3.1.0²,⁶]undecan-9-yl acetate
(2r,15s,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol
C19H24N2O2 (312.18376839999996)